The cumulative live birth rates of 18 593 women with progestin-primed ovarian stimulation-related protocols and frozen-thawed transfer cycles

被引:2
|
作者
Nie, Yunhan [1 ]
Guo, Wenya [1 ]
Shen, Xi [1 ]
Xie, Yating [1 ]
Zeng, Yuqi [1 ]
Gao, Hongyuan [1 ]
Liu, Yali [1 ]
Wang, Li [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Assisted Reprod, Sch Med, Zhi Zao Ju Rd 639, Shanghai 200011, Peoples R China
基金
中国国家自然科学基金;
关键词
cumulative live birth rate; progestin-primed ovarian stimulation-related protocol; frozen embryo transfer; ART; IVF; ICSI; IN-VITRO FERTILIZATION; FERTILIZATION/INTRACYTOPLASMIC SPERM INJECTION; SINGLE-EMBRYO-TRANSFER; PREGNANCY; OOCYTES; NUMBER; IVF;
D O I
10.1093/hropen/hoad051
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
STUDY QUESTION: What are the odds of achieving pregnancy when adopting progestin-primed ovarian stimulation (PPOS)-related protocols combined with repetitive frozen-thawed transfer (FET) cycles in patients with different clinical characteristics?SUMMARY ANSWER: The cumulative live birth rates (CLBRs) of women undergoing different PPOS-related protocols can be significantly and consistently enhanced within six FET cycles when the female age is <40 years (or even <45 years) and when >5 oocytes are retrieved, regardless of antral follicle count (AFC).WHAT IS KNOWN ALREADY: There have been numerous studies on the live birth rate of the first FET cycle in patients with PPOS-related protocols. These studies have focused mainly on comparing pregnancy outcomes with those of other stimulation protocols. However, owing to the unique features of the PPOS-related strategy, such as its flexible timing of oocyte retrieval and repeated transfer of frozen embryos, studies using the CLBR as an overall indicator of success and investigating which types of patients would benefit from this protocol are lacking.STUDY DESIGN, SIZE, DURATION: This retrospective cohort study included 18 593 women who underwent PPOS-related protocols (dydrogesterone + hMG, medroxyprogesterone acetate + hMG, micronized progesterone + hMG treatment, and luteal-phase ovarian stimulation protocol) from 1 March 2011 to 31 September 2022 in our centre.PARTICIPANTS/MATERIALS, SETTING, METHODS: The population was categorized by female age, number of oocytes retrieved, and AFC in the analysis of CLBR within six FET cycles. The age groups (Groups 1-5, respectively) were <30, 30-34, 35-39, 40-44, and >= 45 years. The number of oocytes retrieved was grouped as 1-5, 6-10, 11-15, 16-20, and >20. AFC was grouped as <5, 5-10, 11-15, and >15. The Kaplan-Meier analysis (optimistic method), which hypothesized that patients who did not continue treatment had the same chance of achieving a live birth as those who continued, and the competing risk method (conservative method) which hypothesized they had no chance of achieving a live birth, were applied. In further analyses, the Cox model and Fine-Gray model were adopted: the former corresponds to the optimistic scenario, and the latter corresponds to the pessimistic scenario.MAIN RESULTS AND THE ROLE OF CHANCE: CLBR had a declining trend with female age over six FET cycles (Groups 1-5, respectively: optimistic: 96.9%, 96.6%, 91.4%, 67.3%, and 11.7%; conservative: 87.3%, 85.0%, 74.0%, 41.3%, and 7.5%), requiring more FET cycles to achieve a success rate of at least 50% (Groups 1-5, respectively: optimistic: 2, 2, 2, 4, and >6 cycles; conservative: 2, 2, 2, >,6 and >6 cycles). CLBR showed an increasing trend with the number of oocytes retrieved (Groups 1-5, respectively: optimistic: 93.8%, 94.3%, 95.8%, 96.0%, and 95.6%; conservative: 66.2%, 78.3%, 85.6%, 88.9%, and 91.0%). All groups needed the same number of FET cycles to achieve a success rate of at least 50% (Groups 1-5, respectively: optimistic: 2, 2, 2, 2, and 2 cycles; conservative: 2, 2, 2, 2, and 2 cycles). Furthermore, the CLBR within six FET cycles had an increasing trend with AFC number (Groups 1-4, respectively: optimistic: 89.2%, 94.8%, 95.9%, and 96.3%; conservative: 67.4%, 78.2%, 83.9%, and 88.1%), with all four groups achieving a success rate of at least 50% by the second FET cycle.LIMITATIONS, REASONS FOR CAUTION: The current research is limited by its retrospective design and single-centre nature, which may restrict the generalizability of our findings. WIDER IMPLICATIONS OF THE FINDINGS: This work describes two models (the Kaplan-Meier analysis and the competing risk method) to evaluate the clinical outcome of patients using PPOS-related protocols, which are especially useful for patients of advanced age or those with diminished ovarian reserve. Our findings encourage patients below 45 years old, especially younger than 40 years, and patients with lower AFCs and fewer retrieved oocytes to try this new protocol. Moreover, this study demonstrates the degree of improvement in the CLBR within six FET cycles for patients with different clinical characteristics, providing a valuable point of reference to determine whether to continue ART after a transfer failure.STUDY FUNDING/COMPETING INTEREST(S): The study was supported by grants from the National Natural Science Foundation of China (82071603 to L.W., 82001502 to Y.L.). There are no conflicts of interest to declare.
引用
收藏
页数:11
相关论文
共 43 条
  • [21] Live birth rate and perinatal outcomes following sequential embryo transfer in women with recurrent implantation failure undergoing frozen-thawed embryo transfer cycles
    Jiangman Gao
    Rong Li
    Ping Liu
    Haiyan Wang
    Xiaoyu Long
    BMC Pregnancy and Childbirth, 25 (1)
  • [22] Progesterone supplementation in natural cycles improves live birth rates after embryo transfer of frozen-thawed embryos-a randomized controlled trial
    Wanggren, K.
    Dahlgren Granbom, M.
    Iliadis, S. I.
    Gudmundsson, J.
    Stavreus-Evers, A.
    HUMAN REPRODUCTION, 2022, 37 (10) : 2366 - 2374
  • [23] The role of age and AMH on cumulative live birth rates over multiple frozen-thawed embryo transfer cycles: a study based on low prognosis patients of POSEIDON 3 and 4 groups
    Xia, Lan
    Zhou, Xiaowei
    Wang, Xiaoling
    Zhao, Shen
    Wu, Xian
    Xu, Huihui
    Zhang, Aijun
    Niu, Zhihong
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2024, 22 (01)
  • [24] Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study
    Chen, Hong
    Teng, Xiao Ming
    Sun, Zi Li
    Yao, Di
    Wang, Zheng
    Chen, Zhi Qin
    FERTILITY AND STERILITY, 2022, 118 (04) : 701 - 712
  • [25] Replacing single frozen-thawed euploid embryos in a natural cycle in ovulatory women may increase live birth rates compared to medicated cycles in anovulatory women
    Melnick, Alexis P.
    Setton, Robert
    Stone, Logan D.
    Pereira, Nigel
    Xu, Kangpu
    Rosenwaks, Zev
    Spandorfer, Steven D.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2017, 34 (10) : 1325 - 1331
  • [26] Replacing single frozen-thawed euploid embryos in a natural cycle in ovulatory women may increase live birth rates compared to medicated cycles in anovulatory women
    Alexis P Melnick
    Robert Setton
    Logan D. Stone
    Nigel Pereira
    Kangpu Xu
    Zev Rosenwaks
    Steven D. Spandorfer
    Journal of Assisted Reproduction and Genetics, 2017, 34 : 1325 - 1331
  • [27] Association between endogenous LH level prior to progesterone administration and live birth rate in artificial frozen-thawed blastocyst transfer cycles of ovulatory women
    Zhou, Ruiqiong
    Zhang, Xiqian
    Dong, Mei
    Huang, Li
    Zhu, Xiulan
    Wang, Songlu
    Liu, Fenghua
    HUMAN REPRODUCTION, 2021, 36 (10) : 2687 - 2696
  • [28] Natural cycle frozen-thawed embryo transfer in young women with regular menstrual cycles increases the live-birth rates compared with hormone replacement treatment: a retrospective cohort study
    Liu, Xitong
    Shi, Wenhao
    Shi, Juanzi
    FERTILITY AND STERILITY, 2020, 113 (04) : 811 - 817
  • [29] Cumulative live birth rate of in vitro fertilization cycle via progestin-primed ovarian stimulation versus gonadotropin-releasing hormone antagonist protocol in infertile women with normal ovarian reserve: an open-label, randomized controlled trial
    Ye, Hongjuan
    Shi, Liya
    Quan, Xinxin
    Hou, Min
    Ma, Huilan
    Xue, Songguo
    Yu, Zhao
    Chen, Qiuju
    Sun, Lihua
    HUMAN FERTILITY, 2024, 27 (01)
  • [30] Pretreatment with a GnRH agonist and hormone replacement treatment protocol could not improve live birth rate for PCOS women undergoing frozen-thawed embryo transfer cycles
    Xitong Liu
    Juanzi Shi
    Haiyan Bai
    Wen Wen
    BMC Pregnancy and Childbirth, 21